IP Library › Granted Patent US 12,624,002
Granted Patent B2
US 12,624,002 · App. 17/922,945 · Granted May 12, 2026

Dimers for use in synthesis of peptidomimetics

Inventors: Yousef Al-Abed (Manhasset, NY); Ahmad Altiti (Piscataway, NJ)
Assignee: THE FEINSTEIN INSTITUTES FOR MEDICAL RESEARCH
C07C333/12C07D207/16C07D231/04
View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 12,624,002
App. No.
17/922,945
Granted
May 12, 2026
Kind
B2
Abstract

Dimers for use in synthesis of peptidomimetics are described. Uses of dimers as synthons in synthesis of azapeptides and other peptidomimetics, azapeptides and other peptidomimetics synthesized from the dimers and uses of azapeptides and other peptidomimetics are also described.

Claims (52)

1 . A compound of Formula (I):

and salts thereof, wherein

A is N-phthalimidyl or NR 3 R 4 , wherein (i) R 3 is H and R 4 is 9-fluorenylmethoxycarbonyl or 2-(3,5-dimethoxyphenyl) propan-2-yloxycarbonyl or (ii) R 3 and R 1 are connected and together form a side chain radical of proline and R 4 is tert-butoxycarbonyl, 9-fluorenylmethoxycarbonyl or 2-(3,5-dimethoxyphenyl) propan-2-yloxycarbonyl;

A 1 is H or absent;

A 2 is H or absent;

X is selected from the group consisting of imidazolyl, benzotriazolyl, S-D, and O-L;

D is H, Cl, an alkyl, an aryl or a heteroaryl;

L is imidazolyl or benzotriazolyl;

R 1 and R 2 is each independently selected from the group consisting of side chain radicals of amino acids selected from the group consisting of side chain radicals of aspartic acid, phenylalanine, alanine, histidine, glutamic acid, tryptophan, valine, leucine, lysine, methionine, threonine, tyrosine, isoleucine, arginine, glycine, asparagine, serine, and glutamine;

Z 1 and Z 2 is each independently C or N; and

at least one of Z 1 and Z 2 is N.

2 . A compound of Formula (I):

and salts thereof, wherein

A is NR 3 R 4 , wherein (i) R 3 is H and R 4 is 9-fluorenylmethoxycarbonyl or 2-(3,5-dimethoxyphenyl) propan-2-yloxycarbonyl or (ii) R 3 and R 1 are connected and together form a side chain radical of proline and R 4 is tert-butoxycarbonyl, 9-fluorenylmethoxycarbonyl or 2-(3,5-dimethoxyphenyl) propan-2-yloxycarbonyl;

A 1 is H or absent;

A 2 is H or absent;

X is selected from the group consisting of imidazolyl, benzotriazolyl, S-D, and O-L;

D is H, Cl, an alkyl, an aryl or a heteroaryl;

L is imidazolyl or benzotriazolyl;

R 1 and R 2 is each independently selected from the group consisting of side chain radicals of amino acids selected from the group consisting of side chain radicals of aspartic acid, phenylalanine, alanine, histidine, glutamic acid, tryptophan, valine, leucine, lysine, methionine, threonine, tyrosine, isoleucine, arginine, glycine, asparagine, serine, and glutamine; and

Z 1 is N and Z 2 is C, or Z 1 is C and Z 2 is N.

3 . A compound according to claim 1 , wherein A is NR 3 R 4 , wherein R 3 is H and R 4 is 9-fluorenylmethoxycarbonyl or 2-(3,5-dimethoxyphenyl) propan-2-yloxycarbonyl.

4 . A compound according to claim 1 , wherein A is N-phthalimidyl.

5 . A compound according to claim 1 , wherein A is NR 3 R 4 , R 3 is H, R 4 is 9-fluorenylmethoxycarbonyl or 2-(3,5-dimethoxyphenyl) propan-2-yloxycarbonyl, and R 3 and R 1 are connected and together form a side chain radical of proline.

6 . A compound according to claim 1 , wherein X is benzotriazolyl.

7 . A compound according to claim 1 , wherein X is S-D; and D is an alkyl.

8 . A compound according to claim 7 , wherein the alkyl is ethyl.

9 . A compound according to claim 1 , wherein X is selected from a group consisting of S-D and O-L.

10 . A compound according to claim 2 , wherein X is selected from the group consisting of S-D and O-L.

11 . A compound according to claim 1 , wherein Z 1 and Z 2 are both N.

12 . A compound according to claim 1 , wherein Z 1 is C, and Z 2 is N.

13 . A compound according to claim 1 wherein the side chain radicals of amino acids are selected from the group consisting of side chain radicals of aspartic acid, phenylalanine, alanine, histidine, glutamic acid, tryptophan, valine, leucine, lysine, methionine, threonine, tyrosine, isoleucine, arginine, asparagine, serine, and glutamine.

14 . A compound according to claim 2 , wherein A is NR 3 R 4 , R 3 is H and R 4 is 9-fluorenylmethoxycarbonyl or 2-(3,5-dimethoxyphenyl) propan-2-yloxycarbonyl.

15 . A compound according to claim 14 , wherein R 4 is 9-fluorenylmethoxycarbonyl.

16 . A compound according to claim 1 , wherein X is selected from a group consisting of imidazolyl, benzotriazolyl, and S-D.

17 . A compound according to claim 1 , which is (9H-fluoren-9-yl)methyl 2-(2-benzyl-2-((ethylthio) carbonyl) hydrazine-1-carbonyl) pyrrolidine-1-carboxylate.

18 . A compound according to claim 1 , wherein

A is NR 3 R 4 , and R 3 and R 1 are connected and together form a side chain radical of proline and R 4 is 9-fluorenylmethoxycarbonyl;

A 1 is absent;

A 2 is absent;

Z 1 is C;

Z 2 is N;

X is S-D or O-L; and

L is an alkyl.

19 . A compound according to claim 2 , wherein

A is NR 3 R 4 , and R 3 and R 1 are connected and together form a side chain radical of proline and R 4 is 9-fluorenylmethoxycarbonyl;

A 1 is absent;

A 2 is absent;

Z 1 is C;

Z 2 is N;

X is S-D or O-L; and

L is an alkyl.

Assignments (1)
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Nov 3, 2022
From: AL-ABED, YOUSEF; ALTITI, AHMAD
To: THE FEINSTEIN INSTITUTES FOR MEDICAL RESEARCH
Reel/Frame 061649/0807 →
Continuity (2)
Provisional Application 63021803 · May 8, 2020
Related Publication 20230159450A1 · May 25, 2023
References Cited (83)
US 5157123A · Zara et al. · 1992 [cited by applicant]
US 5202312A · Matsumoto et al. · 1993 [cited by applicant]
US 5602231A · Cotton et al. · 1997 [cited by applicant]
US 5646276A · Robl · 1997 [cited by applicant]
US 6784293B1 · Wu et al. · 2004 [cited by applicant]
US 8563565B2 · Norimine et al. · 2013 [cited by applicant]
US 9186371B2 · Taniguchi et al. · 2015 [cited by applicant]
US 10919882B2 · Al-Abed et al. · 2021 [cited by applicant]
US 11414405B2 · Al-Abed et al. · 2022 [cited by applicant]
US 11440881B2 · Al-Abed et al. · 2022 [cited by applicant]
US 11471507B2 · Al-Abed et al. · 2022 [cited by applicant]
US 11471508B2 · Al-Abed et al. · 2022 [cited by applicant]
US 20060281686A1 · Lopez Areiza et al. · 2006 [cited by applicant]
US 20110086836A1 · Soeberdt et al. · 2011 [cited by applicant]
US 20180344808A1 · Tracey et al. · 2018 [cited by applicant]
US 20190055283A1 · Ekici et al. · 2019 [cited by applicant]
US 20200354404A1 · Al-Abed · 2020 [cited by applicant]
US 20200354418A1 · Al-Abed · 2020 [cited by applicant]
US 20210000908A1 · Al-Abed · 2021 [cited by applicant]
US 20220306577A1 · Al-Abed et al. · 2022 [cited by applicant]
EP 2113513A2 · 2009 [cited by applicant]
GB 826300 · 1957 [cited by applicant]
KR 1020050099732 · 2005 [cited by applicant]
KR 20050099732A · 2005 [cited by applicant]
WO WO2016094899A2 · 2016 [cited by applicant]
WO WO2019007383A1 · 2019 [cited by applicant]
WO WO2019127607A1 · 2019 [cited by applicant]
WO WO2020227592A1 · 2020 [cited by applicant]
Pare Emily C. et al: “Synthesis of 1,5-diisopropyl substituted 6-oxoverdazyls”, Organic & Biomolecular Chemistry, vol. 3, No. 23, Jan. 1, 2005 (Jan. 1, 2005), p. 4258, XP093194141, ISSN: 1477-0520, DOI: 10.1039/b510075e. [cited by applicant]
Rabong Constantin et al: “NXO beta structure mimicry: an ultrashort turn/hairpin mimic that folds in water”, RSC Advances, vol. 4, No. 41, Jan. 1, 2014 (Jan. 1, 2014), pp. 21351-21360, XP093194142, GB ISSN: 2046-2069, D… [cited by applicant]
Abo-Oya Nader E. et al: “Benzotriazole-Mediated Synthesis of Aza-peptides: En Route to an Aza-Leuenkephalin Analogue”, The Journal of Organic Chemistry, vol. 78, No. 8, Apr. 10, 2013 (Apr. 10, 2013), pp. 3541-3552, XP09… [cited by applicant]
Zhou Zhou et al: “Synthesis and Structural Characterization of 2:1 [[alpha]/ Aza]-oligomers”, European Journal of Organic Chemistry, Wiley-VCH, DE, vol. 2014, No. 34, Oct. 21, 2014 (Oct. 21, 2014), pp. 7643-7650, XP0721… [cited by applicant]
PubChem AKOS000648614, Modify Date: Feb. 22, 2011. [cited by applicant]
PubChem 2-(2-(1,3-Dioxoisoindolin-2-yl)acetamido)acetyl chloride, Modify Date: Mar. 31, 2020. [cited by applicant]
PubChem AC1 MBWCP, Modify Date: Mar. 7, 2011. [cited by applicant]
Pérez-Picaso L, Olivo HF, Argotte-Ramos R, Rodríguez-Gutiérrez M, Rios MY. Linear and cyclic dipeptides with antimalarial activity. Bioorg Med Chem Lett. Dec. 1, 2012;22(23):7048-51. doi: 10.1016/j.bmcl.2012.09.094. Epu… [cited by applicant]
Supplementary Partial European Search Report EP21800750.8, mailed on Sep. 24, 2024. [cited by applicant]
Chemical Abstracts Service. STN database. “CAS Registry No. 4976-75-4. CA Index Name: 2-Isoindolineacetic acid, alpha-[2-(methylthio)ethyl]-1,3-dioxo-, 2-carboxyhydrazide, tertbutyl ester, (S)-”. Entered STN: Nov. 16, 1… [cited by applicant]
Chemical Abstracts Service. STN database. “CAS Registry No. 32668-16-9. CA Indexname: Glutaramic acid, 2-phthalimido-, 2-carboxyhydrazide tert-butyl ester, L-”. Entered STN: Nov. 16, 1984. [cited by applicant]
Chemical Abstracts Service. STN database. “CAS Registry No. 2896-89-1.CA Index Name: 2-Isoindolineacetic acid, alpha-isobutyl-1,3-dioxo-, 2-carboxyhydrazide, tert-butyl ester.” Entered STN: Nov. 16, 1984. [cited by applicant]
Chemical Abstracts Service. STN database. “CAS Registry No. 1810074-96-4. CA Index Name: Hydrazinecarbothioic acid, 2-[2-(1,3-dihydro-1,3-dioxo-2H-isoindol-2-yl) acetyl]-, potassium salt”. Entered STN: Oct. 15, 2015. [cited by applicant]
Chemical Abstracts Service. STN database. “CAS Registry No. 892151-00-7. CA Index Name: 2H-Isoindole-2-acetic acid, 1,3-dihydro-1,3-dioxo-,2-(ethoxycarbonyl) hydrazide”. Entered STN: Jul. 12, 2006. [cited by applicant]
Chemical Abstracts Service. STN database. “CAS Registry No. 1810074-95-3. CA Index Name: Hydrazinecarbothioic acid, 2-[2-(1,3-dihydro-1,3-dioxo-2H-isoindol-2-yl)acetyl]-”. Entered STN: Oct. 15, 2015. [cited by applicant]
Abbas C, et al. “Original and efficient synthesis of 2:1 [alpha/aza]-oligomer precursors”. Tetrahedron Letters. Jul. 15, 2009; 50(28):4158-60. [cited by applicant]
PubChem-SID-105195820, Modify Date: May 30, 2019, p. 2, figure. [cited by applicant]
PubChem-SID-405014557, Modify Date: Mar. 31, 2020, p. 2, figure. [cited by applicant]
PubChem-SID-111355128, Modify Date: Mar. 7, 2011, p. 2, figure. [cited by applicant]
Perez-Picaso et al., “Linear and cyclic depeptides with antimalarial activity”, Bioorganic & Medicinal Chemistry Letters, 22 (2012) 7048-7051. [cited by applicant]
International Search Report issued on Sep. 29, 2022, from corresponding International Application No. PCT/US21/31246. [cited by applicant]
Written Opinion of the International Searching Authority issued on Sep. 29, 2022, from corresponding International Application No. PCT/US21/31246. [cited by applicant]
International Search Report issued on Sep. 2, 2020, from corresponding International Application No. PCT/US20/31998. [cited by applicant]
Written Opinion of the International Searching Authority issued on Sep. 2, 2020, from corresponding International Application No. PCT/US20/31998. [cited by applicant]
PubChem CID-136595533 “(2,5-Dioxopyrrol-1-yl) N-(2,5-dihydroxypyrrol-1-yl)-N-(1,3-dioxoisoindol-2-yl)carbamate” Created on Jan. 4, 2019. [cited by applicant]
PubChem CID-132255576 “(2S)-2-(Imidazole-1-carbonylamino)pentanedioic acid” Created on Jan. 29, 2018. [cited by applicant]
International Search Report issued on Jul. 31, 2020, from corresponding International Application No. PCT/US20/32025. [cited by applicant]
Written Opinion of the International Searching Authority issued on Jul. 31, 2020, from corresponding International Application No. PCT/US20/32025. [cited by applicant]
Yang et al. “MD-2 is required for disulfide HMGB1-dependent TLR4 signaling” The Journal of Experimental Medicine; Published on Jan. 5, 2015; vol. 212; p. 5-14. [cited by applicant]
Sun et al. “Folic acid derived-P5779 mimetics regulate DAMP-mediated inflammation through disruption of HMGB1:TLR4:MD-2 axes” PLOS One; Published on Feb. 15, 2018; vol. 13; p. 1-14. [cited by applicant]
International Search Report issued on Sep. 10, 2020, from corresponding International Application No. PCT/US20/31992. [cited by applicant]
Written Opinion of the International Searching Authority issued on Sep. 10, 2020, from corresponding International Application No. PCT/US20/31992. [cited by applicant]
PubChem CID-519335 “Methanethioic S-acid” Created on Mar. 27, 2005. [cited by applicant]
Heffeter et al. “Anticancer Thiosemicarbazones: Chemical Properties, Interaction with Iron Metabolism, and Resistance Development” Antioxidants & Redox Signaling; vol. 30, No. 8, 2019. [cited by applicant]
International Search Report issued on Sep. 16, 2020, from corresponding International Application No. PCT/US20/31988. [cited by applicant]
Written Opinion of the International Searching Authority issued on Sep. 16, 2020, from corresponding International Application No. PCT/US20/31988. [cited by applicant]
PubChem CID-67548889 “Methyl (2S)-1-(imidazole-1-carbonyl)pyrrolidine-2-carboxylate” Created on Nov. 30, 2012. [cited by applicant]
PubChem CID-1089188 “(2s)-1-(1-Imidazolylcarbonyl)pyrrolidine-2-carboxylic acid benzyl ester” Created on Oct. 26, 2006. [cited by applicant]
Abo-Dya, N.E., Biswas, S., Basak, A., Avan, I., Alamry, K.A., and Katritzky, A.R., Benzotriazole-Mediated Synthesis of Aza-peptides: En Route to an Aza-Leuenkephalin Analogue. The Journal of Organic Chemistry 78, 3541-3… [cited by applicant]
Avan, I., Hall, C.D., and Katritzky, A.R., Peptidomimetics via modifications of amino acids and peptide bonds. Chemical Society Reviews 43, 3575-3594 (2014). [cited by applicant]
Andre etal., Tetrahedron Letters, vol. 37, No. 2, pp. 183-186, 1996 (Year: 1996). [cited by applicant]
The Chemistry of Benzotriazole Derivatives, Monbaliu, Ed., Topic in Heterocyclic Chemistry, Springer, 2016, cover page to p. 2, p. 69 and pp. 95-142 provided (Year: 2016). [cited by applicant]
Triphosgene Product Data Sheet, Aldrich Chemical Company, 2 pages, 1996 (Year: 1996). [cited by applicant]
Scientific Update 2014 regarding Deprotection when using Phthalimide, 2 pages, obtained online Aug. 28, 2021 from https://archive.is/20141203032450/http://scientificupdate.co .uk/process-chemistry-information/item/depro… [cited by applicant]
Suppo et al., Org. Synth. 2015, 92, 296-308 (Year: 2015). [cited by applicant]
Verma et al., Hindawi Publishing Corporation, Journal of Chemistry, vol. 2013, Article ID 329412, 12 pages (Year: 2013). [cited by applicant]
Boeglin and Lubell, J. Comb. Chem., 7, 864-878 (2005) (Year: 2005). [cited by applicant]
Che and Marshall, Biopolymers, 2006, 81, 392-406 (Year: 2006). [cited by applicant]
Mcarthur et al., Syn. Commns., 13:5, 393-401 (1983) (Year: 1983). [cited by applicant]
Sigma-Aldrich Amino Acids Reference Chart, 2014, downloaded from the internet Aug. 4, 2014 (Year: 2014). [cited by applicant]
Riemschneider, R. Jacs 1955, 844-8471. [cited by applicant]
“1824108-09-9”, XP093155567, Chemical Abstract Service, Columbus, Ohio, US; Database accession No. 1824108-09-9, Dec. 7, 2015. [cited by applicant]
L.N. Akimova: “Microstructure of protein X Substituted N-Aminoacyl derivatives of dioxopiperazines”. XP093155572, Chemical Abstract Service, Columbus, Ohio, US; Database accession No. 1952:7041, Jan. 1, 1952. [cited by applicant]
O.L. Salerni et al., “ [cited by applicant]
PubChem-SID-13078240, Modify Date: Apr. 27, 2024. [cited by applicant]